# Antimalarial Potential of Heme-Targeting Dimeric Compounds: Binding Efficacy vs. Membrane Retention Effects

## TL;DR

This paper explores dimeric compounds targeting heme in malaria parasites, finding they bind well but have limited antimalarial activity due to poor membrane retention.

## Contribution

The study introduces dimeric 3-alkylpyridine derivatives as heme-targeting compounds and reveals their pharmacokinetic limitations.

## Key findings

- Dimeric compounds show strong heme-binding affinity confirmed by UV–vis spectroscopy and computational methods.
- Antimalarial activity is limited with IC50 values of 46–140 μM due to poor intracellular availability.
- Compounds penetrate lipid bilayers but remain trapped, highlighting the role of physicochemical properties in drug efficacy.

## Abstract

Malaria, caused by
Plasmodium parasites, remains a major global
health burden with high morbidity and mortality rates. Despite the
availability of treatments, the therapeutic arsenal is limited, and
drug resistance poses a significant challenge. Thus, discovering new
antimalarial compounds is critical, and understanding their mechanisms
of action is key. One well-studied target is the heme group, which
plays a central role in the degradation of the parasite’s hemoglobin
and infection success. This study describes the dimerization of 3-alkylpyridine
derivatives, a class of compounds known to interact with heme, with
the aim of enhancing their antimalarial activity. The dimers were
analyzed for heme-binding affinity via UV–vis spectroscopy
(K
d determination) and further investigated
through semiempirical GFN2-xTB and with the B97–3c functional
with double (def2-SVP) and triple (def2-TZVP) zeta basis set quality,
confirming effective interaction. However, antimalarial assays revealed
modest IC50 values (46–140 μM). In silico membrane permeation
studies showed that the compounds penetrate lipid bilayers effectively.
However, they remain trapped within the membrane for a long time,
which may reduce their intracellular availability and limit their
efficacy. Although these compounds exhibit strong target binding,
their antimalarial activity is hindered by unfavorable pharmacokinetic
properties. These findings emphasize the importance of physicochemical
properties in antimalarial drug development and suggest that advanced
drug delivery systems could overcome these limitations in future studies.